Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001410578-24-001706
Filing Date
2024-10-29
Accepted
2024-10-29 17:03:31
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A clrb-20240331x10qa.htm   iXBRL 10-Q/A 1607983
2 EX-31.1 clrb-20240331xex31d1.htm EX-31.1 11080
3 EX-31.2 clrb-20240331xex31d2.htm EX-31.2 11078
4 EX-32.1 clrb-20240331xex32d1.htm EX-32.1 9854
  Complete submission text file 0001410578-24-001706.txt   8053142

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20240331.xsd EX-101.SCH 38100
6 EX-101.CAL clrb-20240331_cal.xml EX-101.CAL 28799
7 EX-101.DEF clrb-20240331_def.xml EX-101.DEF 234451
8 EX-101.LAB clrb-20240331_lab.xml EX-101.LAB 276627
9 EX-101.PRE clrb-20240331_pre.xml EX-101.PRE 337267
63 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20240331x10qa_htm.xml XML 1815918
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36598 | Film No.: 241406542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)